Leerink Partners sets $23.00 share price target for Amneal Pharmaceuticals
Leerink Partners announced a $23.00 per-share price target for Amneal Pharmaceuticals, according to ratings actions cited.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.